Janus Henderson Group PLC Fibrogen Inc Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$2.49 - $20.59 $1.09 Million - $9.05 Million
-439,459 Reduced 90.3%
47,193 $127,000
Q1 2023

May 15, 2023
BUY
$15.95 - $25.18 $1.77 Million - $2.79 Million
110,808 Added 29.48%
486,652 $9.08 Million
Q4 2022

Feb 14, 2023
BUY
$13.27 - $17.73 $4.77 Million - $6.37 Million
359,198 Added 2157.86%
375,844 $6.02 Million
Q3 2022

Nov 14, 2022
SELL
$11.4 - $14.6 $262 - $335
-23 Reduced 0.14%
16,646 $217,000
Q2 2022

Aug 15, 2022
BUY
$7.94 - $12.96 $230 - $375
29 Added 0.17%
16,669 $176,000
Q1 2022

May 16, 2022
BUY
$12.02 - $16.79 $36 - $50
3 Added 0.02%
16,640 $200,000
Q4 2021

Feb 14, 2022
BUY
$9.93 - $15.39 $165,205 - $256,043
16,637 New
16,637 $235,000
Q3 2021

Nov 16, 2021
SELL
$10.18 - $26.64 $12.5 Million - $32.6 Million
-1,224,474 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$18.57 - $35.68 $38.3 Million - $73.5 Million
-2,059,793 Reduced 62.72%
1,224,474 $32.6 Million
Q1 2021

May 17, 2021
SELL
$31.0 - $55.72 $3.58 Million - $6.43 Million
-115,417 Reduced 3.39%
3,284,267 $114 Million
Q4 2020

Feb 16, 2021
BUY
$37.09 - $48.97 $3.36 Million - $4.44 Million
90,719 Added 2.74%
3,399,684 $126 Million
Q3 2020

Nov 16, 2020
BUY
$40.47 - $45.5 $4.2 Million - $4.72 Million
103,815 Added 3.24%
3,308,965 $136 Million
Q2 2020

Aug 14, 2020
BUY
$32.57 - $42.83 $4.04 Million - $5.32 Million
124,164 Added 4.03%
3,205,150 $130 Million
Q1 2020

May 14, 2020
BUY
$23.3 - $45.96 $10.3 Million - $20.3 Million
441,296 Added 16.72%
3,080,986 $107 Million
Q4 2019

Feb 18, 2020
SELL
$34.58 - $48.06 $1.13 Million - $1.57 Million
-32,614 Reduced 1.22%
2,639,690 $113 Million
Q3 2019

Nov 14, 2019
BUY
$36.98 - $48.45 $6.35 Million - $8.32 Million
171,737 Added 6.87%
2,672,304 $98.8 Million
Q2 2019

Jul 31, 2019
BUY
$35.13 - $55.53 $10.3 Million - $16.2 Million
291,808 Added 13.21%
2,500,567 $113 Million
Q1 2019

Apr 30, 2019
BUY
$42.83 - $59.91 $20.3 Million - $28.3 Million
473,042 Added 27.25%
2,208,759 $120 Million
Q4 2018

Feb 06, 2019
BUY
$37.97 - $60.16 $19.6 Million - $31.1 Million
516,476 Added 42.36%
1,735,717 $80.3 Million
Q3 2018

Nov 09, 2018
SELL
$56.3 - $67.25 $8.82 Million - $10.5 Million
-156,742 Reduced 11.39%
1,219,241 $74.1 Million
Q2 2018

Aug 10, 2018
SELL
$44.9 - $64.95 $27.1 Million - $39.2 Million
-603,369 Reduced 30.48%
1,375,983 $86.1 Million
Q1 2018

May 14, 2018
SELL
$45.35 - $61.65 $684,059 - $929,928
-15,084 Reduced 0.76%
1,979,352 $91.4 Million
Q4 2017

Feb 09, 2018
BUY
$41.95 - $60.1 $25.4 Million - $36.4 Million
605,715 Added 43.62%
1,994,436 $94.5 Million
Q3 2017

Nov 14, 2017
SELL
$33.4 - $53.9 $804,205 - $1.3 Million
-24,078 Reduced 1.7%
1,388,721 $0
Q2 2017

Aug 17, 2017
BUY
N/A
1,412,799
1,412,799 $45.6 Million

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email